JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

NCT06973564 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: JAB-23E73
DRUG: JAB-23E73
DRUG: JAB-23E73

Sponsor

Jacobio Pharmaceuticals Co., Ltd.